Hyperthermic intraperitoneal chemotherapy after upfront cytoreductive surgery for stage III epithelial ovarian cancer: Follow-up of long-term survival.

Acta Obstet Gynecol Scand · 2025 · PMC11981111 · PMID 40035363

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significancep = 0.060so close (0.05 < p ≤ 0.1)

The 5‐year OS rate was 22.4% (95% CI, 15.1%–30.5%) in the surgery‐plus‐HIPEC group and 12.2% (95% CI, 4.4%–24.2%) in the surgery‐alone group, but the difference did not reach statistical significance ( p = 0.060).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.